Literature DB >> 23998912

Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Rodrigo Machado-Vieira1, Marcio G Soeiro-De-Souza, Erica M Richards, Antonio L Teixeira, Carlos A Zarate.   

Abstract

OBJECTIVES: This paper reviews the neurobiology of bipolar disorder (BD), particularly findings associated with impaired cellular resilience and plasticity.
METHODS: PubMed/Medline articles and book chapters published over the last 20 years were identified using the following keyword combinations: BD, calcium, cytokines, endoplasmic reticulum (ER), genetics, glucocorticoids, glutamate, imaging, ketamine, lithium, mania, mitochondria, neuroplasticity, neuroprotection, neurotrophic, oxidative stress, plasticity, resilience, and valproate.
RESULTS: BD is associated with impaired cellular resilience and synaptic dysfunction at multiple levels, associated with impaired cellular resilience and plasticity. These findings were partially prevented or even reversed with the use of mood stabilizers, but longitudinal studies associated with clinical outcome remain scarce.
CONCLUSIONS: Evidence consistently suggests that BD involves impaired neural plasticity and cellular resilience at multiple levels. This includes the genetic and intra- and intercellular signalling levels, their impact on brain structure and function, as well as the final translation into behaviour/cognitive changes. Future studies are expected to adopt integrated translational approaches using a variety of methods (e.g., microarray approaches, neuroimaging, genetics, electrophysiology, and the new generation of -omics techniques). These studies will likely focus on more precise diagnoses and a personalized medicine paradigm in order to develop better treatments for those who need them most.

Entities:  

Mesh:

Year:  2013        PMID: 23998912      PMCID: PMC4180367          DOI: 10.3109/15622975.2013.830775

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  93 in total

1.  Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.

Authors:  John D Port; Sencan S Unal; David A Mrazek; Susan M Marcus
Journal:  Psychiatry Res       Date:  2007-12-31       Impact factor: 3.222

Review 2.  Genetics of bipolar disorder: successful start to a long journey.

Authors:  Nick Craddock; Pamela Sklar
Journal:  Trends Genet       Date:  2009-01-12       Impact factor: 11.639

3.  Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD.

Authors:  Heike Weber; Sarah Kittel-Schneider; Alexandra Gessner; Katharina Domschke; Maria Neuner; Christian P Jacob; Henriette N Buttenschon; Andrea Boreatti-Hümmer; Julia Volkert; Sabine Herterich; Bernhard T Baune; Silke Gross-Lesch; Juliane Kopf; Susanne Kreiker; Thuy Trang Nguyen; Lena Weissflog; Volker Arolt; Ole Mors; Jürgen Deckert; Klaus-Peter Lesch; Andreas Reif
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

4.  Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

Authors:  J Cui; L Shao; L T Young; J-F Wang
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

Review 5.  Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis.

Authors:  Christine Konradi; Stephanie E Sillivan; Hayley B Clay
Journal:  Neurobiol Dis       Date:  2011-02-17       Impact factor: 5.996

6.  Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.

Authors:  Francesco Benedetti; Alessandro Serretti; Adriana Pontiggia; Alessandro Bernasconi; Cristina Lorenzi; Cristina Colombo; Enrico Smeraldi
Journal:  Neurosci Lett       Date:  2004-12-10       Impact factor: 3.046

7.  Increased levels of glutamate in brains from patients with mood disorders.

Authors:  Kenji Hashimoto; Akira Sawa; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2007-06-15       Impact factor: 13.382

Review 8.  The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors.

Authors:  Stephen D Skaper
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-02       Impact factor: 4.388

9.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

10.  The role of BDNF as a mediator of neuroplasticity in bipolar disorder.

Authors:  Iria Grande; Gabriel Rodrigo Fries; Mauricio Kunz; Flavio Kapczinski
Journal:  Psychiatry Investig       Date:  2010-12-15       Impact factor: 2.505

View more
  24 in total

1.  Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder.

Authors:  Rafael T de Sousa; Emilio L Streck; Orestes V Forlenza; Andre R Brunoni; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Luis V Portela; André F Carvalho; Carlos A Zarate; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Neurosci Lett       Date:  2015-08-20       Impact factor: 3.046

Review 2.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

3.  Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.

Authors:  Rodrigo Machado-Vieira; Marcus V Zanetti; Antonio L Teixeira; Miyuki Uno; Leandro L Valiengo; Marcio G Soeiro-de-Souza; Sueli M Oba-Shinjo; Rafael T de Sousa; Carlos A Zarate; Wagner F Gattaz; Suely K N Marie
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-16       Impact factor: 4.600

Review 4.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

5.  Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

Authors:  Rafael T de Sousa; Carlos A Zarate; Marcus V Zanetti; Alana C Costa; Leda L Talib; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

6.  Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.

Authors:  Rodrigo Machado-Vieira; Marcus V Zanetti; Maria C Otaduy; Rafael T De Sousa; Marcio G Soeiro-de-Souza; Alana C Costa; Andre F Carvalho; Claudia C Leite; Geraldo F Busatto; Carlos A Zarate; Wagner F Gattaz
Journal:  J Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.153

7.  Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission.

Authors:  Sarah Delcourte; Erika Abrial; Adeline Etiévant; Renaud Rovera; Jørn Arnt; Michael Didriksen; Nasser Haddjeri
Journal:  CNS Neurosci Ther       Date:  2017-04-17       Impact factor: 5.243

8.  Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment.

Authors:  Antonio L Teixeira; Rafael Teixeira de Sousa; Rafael T de Souza; Marcus V Zanetti; Andre R Brunoni; Geraldo F Busatto; Carlos A Zarate; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Hum Psychopharmacol       Date:  2015-01       Impact factor: 1.672

9.  Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.

Authors:  Rafael T de Sousa; Emilio L Streck; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Andre R Brunoni; Geraldo F Busatto; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Psychopharmacology (Berl)       Date:  2014-06-26       Impact factor: 4.530

10.  Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility.

Authors:  C Nasca; B Bigio; D Zelli; F Nicoletti; B S McEwen
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.